102 related articles for article (PubMed ID: 702944)
1. Antihypertensive and antidiuretic effects of 3-hydrazino-6-[N, N-bis (2-hydroxyethyl) amino]-pyridazine (L 6150) in rats.
Watanabe TX; Shiono K; Saito K; Sokabe H
Jpn J Pharmacol; 1978 Jun; 28(3):413-22. PubMed ID: 702944
[TBL] [Abstract][Full Text] [Related]
2. Effect of 3-hydrazino-6[N, N-bis (2-hydroxyethyl) amino]-pyridazine (L 6150) on renin in hypertensive rats.
Kawashima K; Watanabe TX; Sokabe H
Jpn J Pharmacol; 1980 Feb; 30(1):116-8. PubMed ID: 6995653
[No Abstract] [Full Text] [Related]
3. Disposition and metabolism of 3-hydrazino-6-[N,N-bis(2-hydroxyethyl)amino] pyridazine dihydrochloride in man.
Assandri A; Perazzi A; Buniva G; Pagani V
Eur J Drug Metab Pharmacokinet; 1979; 4(2):75-82. PubMed ID: 488135
[No Abstract] [Full Text] [Related]
4. A comparative study of the hemodynamic effects of single intravenous doses of 3-hydrazino-6-[N,N-bis-(2-hydroxyethyl)-amino]-pyridazine-dihydrochloride and hydralazine.
De Ponti C; Bardi U; Marchetti M
Arzneimittelforschung; 1976; 26(11):2089-92. PubMed ID: 1037254
[TBL] [Abstract][Full Text] [Related]
5. Systemic and coronary haemodynamic effects of the new hypotensive drug L 6150.
Maseri A; Pesola A; L'Abbate A; Contini C; Magini G
J Int Med Res; 1976; 4(6):402-9. PubMed ID: 1027634
[TBL] [Abstract][Full Text] [Related]
6. [Mechanism of action of a new hypotensive agent: 3-hydrazino-6-(N,N-bis-(2-hydroxyethyl)-amino)-pyridazine chlorhydrate (L 6150)].
Baldoli E; Sardi A; Caravaggi AM; Bianchi G
Boll Chim Farm; 1972 Aug; 111(8):480-8. PubMed ID: 4647088
[No Abstract] [Full Text] [Related]
7. Onthe pharmacology of 3-hydrazino-6-(N,N-bis(2-hydroxyethyl)amino)-pyridazine-dihydrochloride (L 6150).
Baldoli E; Sardi A; Dezulian V; Capellini M; Bianchi G
Arzneimittelforschung; 1973 Nov; 23(11):1591-5. PubMed ID: 4801666
[No Abstract] [Full Text] [Related]
8. Metabolites of 3-hydrazino-6-[bis-(2-hydroxyethyl)amino]pyridazine dihydrochloride in rat urine.
Beretta E; Cristina T; Ferrari P; Tuan G; Zerilli LF; Martinelli E
Eur J Drug Metab Pharmacokinet; 1979; 4(1):29-33. PubMed ID: 38122
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of three metabolites of 3-hydrazino-6-[bis-(2-hydroxyethyl)amino]pyridazine. A new rearrangement of 3-[1-methylethyliden)hydrazino] derivative.
Bellasio E; Campi A
Farmaco Sci; 1978 Aug; 33(8):565-72. PubMed ID: 744255
[TBL] [Abstract][Full Text] [Related]
10. [Antihypertensive effects of SA446, hydralazine and the combination on renal hypertensive rats and spontaneously hypertensive rats by long-term treatment].
Nakata K; Nishimura K; Takada T; Yamauchi H; Iso T
Nihon Yakurigaku Zasshi; 1986 Feb; 87(2):113-21. PubMed ID: 3699625
[TBL] [Abstract][Full Text] [Related]
11. Effects of the vasodilator endralazine given with the antihypertensive agent guanfacine on heart rate and blood pressure of spontaneously hypertensive rats and normotensive dogs.
Salzmann R; Gerber W; Pally C; Scholtysik G
J Pharm Pharmacol; 1983 May; 35(5):293-8. PubMed ID: 6134797
[TBL] [Abstract][Full Text] [Related]
12. Chronic effects of a beta-adrenoceptor blocking drug, 4-[3-(tert-butylamino)-2-hydroxypropoxy]-N-methylisocarbostyril hydrochloride (N-696), in hypertensive rats.
Kubota N; Kishi K; Sokabe H; Kawashima K; Ishii Y; Kawase S
J Pharmacobiodyn; 1985 Feb; 8(2):134-41. PubMed ID: 2861268
[TBL] [Abstract][Full Text] [Related]
13. Studies on the mechanism of the acute antihypertensive and vasodilator actions of several beta-adrenoceptor antagonists.
Sybertz EJ; Baum T; Pula KK; Nelson S; Eynon E; Sabin C
J Cardiovasc Pharmacol; 1982; 4(5):749-58. PubMed ID: 6182405
[TBL] [Abstract][Full Text] [Related]
14. Hypotensive and diuretic actions of diltiazem in spontaneously hypertensive and Wistar Kyoto rats.
Narita H; Nagao T; Yabana H; Yamaguchi I
J Pharmacol Exp Ther; 1983 Nov; 227(2):472-7. PubMed ID: 6631726
[TBL] [Abstract][Full Text] [Related]
15. The effects of 3-hydrazine-6[N,N-bis(2-hydroxyethyl)-amino]-pyridazine dihydrochloride (L6150) on the general and cardiac haemodynamics of the intact dog.
Maxwell GM
Clin Exp Pharmacol Physiol; 1976; 3(4):343-8. PubMed ID: 975622
[TBL] [Abstract][Full Text] [Related]
16. Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats.
Duarte J; Pérez-Palencia R; Vargas F; Ocete MA; Pérez-Vizcaino F; Zarzuelo A; Tamargo J
Br J Pharmacol; 2001 May; 133(1):117-24. PubMed ID: 11325801
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, hypotensive and diuretic activities of several 3-hydrazino-5,6-dihydrobenzo[h]cinnolines. Part 10: Pyridazine derivatives.
Ravina E; Fueyo J; Teran C; Cid J; Garcia Mera G; Orallo F; Bardan B
Pharmazie; 1992 Aug; 47(8):574-7. PubMed ID: 1438508
[No Abstract] [Full Text] [Related]
18. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
Jackson EK; Dubinion JH; Mi Z
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of nebivolol and hydrochlorothiazide combination in spontaneously hypertensive rats.
Wang Y; Evangelista S; Liu Y; Zhang MS
J Int Med Res; 2013 Jun; 41(3):603-17. PubMed ID: 23680668
[TBL] [Abstract][Full Text] [Related]
20. Antihypertensive activity of cadralazine in experimental hypertensive rats.
Takeyama K; Ikeno A; Minato H; Fukuya F; Nishimura S; Hosoki K; Kadokawa T
Arch Int Pharmacodyn Ther; 1988; 291():163-74. PubMed ID: 3365060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
